{
    "Trade/Device Name(s)": [
        "HemosIL SynthASil"
    ],
    "Submitter Information": "Instrumentation Laboratory Company",
    "510(k) Number": "K060688",
    "Predicate Device Reference 510(k) Number(s)": [
        "K953981"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GFO"
    ],
    "Summary Letter Date": "March 14, 2006",
    "Summary Letter Received Date": "March 15, 2006",
    "Submission Date": "March 14, 2006",
    "Regulation Number(s)": [
        "21CFR864.7925"
    ],
    "Regulation Name(s)": [
        "Partial Thromboplastin Time Tests"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Activated Partial Thromboplastin Time (APTT)"
    ],
    "Specimen Type(s)": [
        "Human citrated plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IL Coagulation Systems",
        "ELECTRA Systems",
        "ACL Futura",
        "ACL Advance",
        "ACL TOP"
    ],
    "Method(s)/Technology(ies)": [
        "Synthetic phospholipid reagent",
        "In vitro determination"
    ],
    "Methodologies": [
        "APTT determination",
        "APTT substitution test"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL SynthASil synthetic phospholipid reagent for APTT determination on IL coagulation analyzers",
    "Indications for Use Summary": "For in vitro determination of APTT in human citrated plasma for evaluation of intrinsic coagulation pathway, APTT substitution test, and monitoring of heparin therapy",
    "fda_folder": "Hematology"
}